Literature DB >> 15675827

Glucose reaction with fumonisin B1 partially reduces its toxicity in swine.

Guillermo Fernández-Surumay1, Gary D Osweiler, Michael J Yaeger, Catherine C Hauck, Suzanne Hendrich, Patricia A Murphy.   

Abstract

Acute and subacute intraperitoneal doses of fumonisin B(1) (FB(1)) were administered to test the efficacy of the FB(1)-glucose reaction products in detoxifying FB(1) in swine. In the acute study at 11 mumol of FB(1)/kg of body weight, five of six pigs administered FB(1) and four of six pigs administered FB(1)-glucose died from acute pulmonary edema. Analysis of weight gain, serum aspartate aminotransferase and gamma-glutamyltransferase, total cholesterol, and pathological evaluation did not provide evidence of protection against FB(1) toxicity by the FB(1)-glucose reaction products. In the subacute study at 5.5 mumol of FB(1)/kg of body weight, one pig administered FB(1) died from liver damage. Analysis of serum aspartate aminotransferase, gamma-glutamyltransferase, and total bilirubin showed protection against FB(1) toxicity by the FB(1)-glucose reaction products. The levels of sphinganine and sphinganine/sphingosine ratios in serum and liver as well as pathologic findings provided definitive evidence of protection against the FB(1) toxic effects by this detoxification procedure (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15675827     DOI: 10.1021/jf048981c

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

1.  Bioaccessibility of total bound fumonisin from corn flakes.

Authors:  E L Motta; P M Scott
Journal:  Mycotoxin Res       Date:  2009-11-17       Impact factor: 3.833

2.  Enzyme characteristics of aminotransferase FumI of Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B₁.

Authors:  Doris Hartinger; Heidi Schwartz; Christian Hametner; Gerd Schatzmayr; Dietmar Haltrich; Wulf-Dieter Moll
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-19       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.